The company has been formed through the transfer of IP and scientific personnel from LigaTrap Technologies, to develop and scale next-generation purification technologies.
Pat brings over a decade of experience in the bioprocessing industry, with deep expertise in downstream purification and the design and development of chromatography media.
"We're delighted to bring Steve on board to partner with us in helping to guide our investments."
The €10 million investment will support the company’s next phase of growth alongside majority shareholders Qualium Investissement and Lauxera
Series A financing, led by M Ventures, highlights the potential impact of Abselion’s technology for life science research and bioprocess development
Chris Major guests on the 'Evaluating Biopharma' podcast for Episode 22: 'Insider’s Advice for Starting, Growing, Exiting a Biotech'.
Acceleration of Bioprocess Development: IRUBIS secures Pre-Series A Funding led by BioProcess360 Partners
BioProcess360 Partners launch dedicated Life Sciences investment fund to grow emerging bioprocessing tools and technologies.
BioProcess360 parent company, Rabbit Run Partners, contributes to Series A Funding Round for Parhelia Biosciences.
